This would be in agreement with the previously reported lack of activation of the PERK-eIF2α in sCJD, in contrast to what is observed in AD [94] suggesting the presence of specific ER-stress responses in both diseases. This evidence concerns the gene EIF2AK3 and Alzheimer disease.